Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$11M Sell
31,297
-693
-2% -$247K 3.21% 8
2025
Q4
$10.5M Sell
31,990
-226
-0.7% -$71.7K 2.93% 9
2025
Q3
$9.09M Sell
32,216
-428
-1% -$124K 2.67% 10
2025
Q2
$9.11M Sell
32,644
-212
-0.6% -$60.1K 2.88% 9
2025
Q1
$10.2M Buy
32,856
+711
+2% +$210K 3.44% 6
2024
Q4
$8.38M Sell
32,145
-604
-2% -$179K 2.95% 9
2024
Q3
$10.6M Buy
32,749
+10
+0% +$3.27K 3.65% 6
2024
Q2
$10.2M Sell
32,739
-234
-0.7% -$68.7K 3.71% 7
2024
Q1
$9.37M Sell
32,973
-290
-0.9% -$84.9K 3.42% 6
2023
Q4
$9.58M Sell
33,263
-701
-2% -$191K 3.75% 6
2023
Q3
$9.13M Sell
33,964
-220
-0.6% -$54.9K 3.85% 6
2023
Q2
$7.59M Sell
34,184
-130
-0.4% -$30.2K 3.14% 9
2023
Q1
$8.3M Buy
34,314
+5
+0% +$1.23K 3.54% 6
2022
Q4
$9.01M Buy
34,309
+250
+0.7% +$67K 3.88% 6
2022
Q3
$7.68M Sell
34,059
-109
-0.3% -$26.4K 3.54% 7
2022
Q2
$8.31M Buy
34,168
+56
+0.2% +$13.7K 3.54% 7
2022
Q1
$8.25M Buy
34,112
+575
+2% +$132K 3.09% 9
2021
Q4
$7.54M Buy
33,537
+465
+1% +$98.1K 2.73% 12
2021
Q3
$7.03M Sell
33,072
-45
-0.1% -$10.4K 2.77% 13
2021
Q2
$8.07M Sell
33,117
-830
-2% -$204K 3.87% 6
2021
Q1
$8.45M Sell
33,947
-535
-2% -$128K 4.26% 5
2020
Q4
$7.93M Sell
34,482
-880
-2% -$203K 4.41% 6
2020
Q3
$8.99M Buy
35,362
+595
+2% +$147K 5.83% 3
2020
Q2
$8.2M Sell
34,767
-285
-0.8% -$65K 5.71% 4
2020
Q1
$7.11M Buy
35,052
+105
+0.3% +$22.9K 5.62% 4
2019
Q4
$8.43M Sell
34,947
-230
-0.7% -$50.7K 5.19% 4
2019
Q3
$6.81M Buy
35,177
+3,240
+10% +$622K 4.5% 6
2019
Q2
$5.88M Sell
31,937
-75
-0.2% -$13.4K 4.19% 6
2019
Q1
$6.08M Sell
32,012
-100
-0.3% -$19.1K 4.53% 5
2018
Q4
$6.25M Sell
32,112
-3,025
-9% -$590K 5.27% 3
2018
Q3
$7.28M Sell
35,137
-825
-2% -$163K 4.7% 3
2018
Q2
$6.64M Sell
35,962
-510
-1% -$90.2K 4.59% 3
2018
Q1
$6.22M Sell
36,472
-375
-1% -$68.8K 4.37% 4
2017
Q4
$6.41M Sell
36,847
-2,215
-6% -$392K 4.26% 4
2017
Q3
$7.28M Buy
39,062
+135
+0.3% +$23.9K 4.74% 3
2017
Q2
$6.7M Sell
38,927
-323
-0.8% -$52.5K 4.37% 3
2017
Q1
$6.44M Sell
39,250
-1,007
-3% -$167K 4.16% 4
2016
Q4
$5.89M Sell
40,257
-288
-0.7% -$43.3K 3.69% 4
2016
Q3
$6.76M Buy
40,545
+165
+0.4% +$27.9K 4.45% 3
2016
Q2
$6.14M Sell
40,380
-229
-0.6% -$35.6K 4.08% 3
2016
Q1
$6.09M Buy
40,609
+85
+0.2% +$12.6K 4.04% 3
2015
Q4
$6.58M Sell
40,524
-185
-0.5% -$29.1K 4.27% 3
2015
Q3
$5.63M Sell
40,709
-110
-0.3% -$17.3K 3.85% 4
2015
Q2
$6.27M Sell
40,819
-305
-0.7% -$48.9K 3.86% 4
2015
Q1
$6.57M Buy
41,124
+450
+1% +$70.9K 4.09% 2
2014
Q4
$6.48M Buy
40,674
+185
+0.5% +$28.8K 4.01% 4
2014
Q3
$5.69M Buy
40,489
+168
+0.4% +$21.9K 3.71% 6
2014
Q2
$4.77M Sell
40,321
-1,120
-3% -$130K 3.12% 12
2014
Q1
$5.11M Sell
41,441
-25
-0.1% -$3.03K 3.29% 7
2013
Q4
$4.73M Sell
41,466
-310
-0.7% -$35.3K 3.16% 8
2013
Q3
$4.68M Buy
41,776
+60
+0.1% +$6.51K 3.49% 7
2013
Q2
$4.12M Buy
+41,716
New +$4.33M 3.17% 10

Other funds holding AMGN

Van Strum & Towne's AMGN Position: Q1 2026 in Review

Van Strum & Towne reduced its Amgen (AMGN) stake by 2.2% in Q1 2026, selling an estimated $247K and leaving 31,297 shares worth $11M. The position accounts for 3.21% of the portfolio, ranked #8.

Van Strum & Towne first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Van Strum & Towne held 31,297 shares of Amgen worth $11M as of Q1 2026.
  • Van Strum & Towne sold 693 Amgen shares in Q1 2026, an estimated $247K.
  • Amgen made up 3.21% of Van Strum & Towne's portfolio in Q1 2026, its #8 holding.
  • Van Strum & Towne first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
  • 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Van Strum & Towne's 13F filing for Q1 2026, filed 7 May 2026.